In a regulatory filing, Janux Therapeutics disclosed that its Acting CFO Tighe Reardon bought 850K shares of common stock on November 13th in a total transaction size of $4.99M.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on JANX: